April 13, 2025
Many of our patients depend on ACA marketplace coverage to access essential care. It is critical that the enrollment processes remain clear, predictable, and easily actionable. Furthermore, patients need affordable and comprehensive coverage that allows them to follow a treatment plan developed by, or in consultation with, a clinician with expertise in CLL. This coverage must also ensure access to prescribed medications, tests, and other necessary services.
The Centers for Medicare and Medicaid Services (CMS) recently proposed changes to the ACA Marketplace process and requirements, which CLL Society believes could disrupt coverage, create administrative and financial burdens for providers, and negatively affect patients with chronic conditions. Proposed changes include shortening the annual open enrollment period, implementing new verifications for special enrollment periods, and introducing new premiums for auto-reenrolled patients. While these efforts aim to address adverse selection and reduce waste, fraud, and abuse, CLL Society views them as misdirected.
In April 2025, CLL Society submitted a letter to CMS addressing these concerns. For more details, read the full letter below.
